Healthcare provider profile · identity verified

Dexter Runa Casta, M.D.

Internal Medicine · LITCHFIELD, MN · NPI 1194043034

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	543	155
Prednisone	Prednisone	459	379
Spironolactone	Spironolactone	390	119
Gabapentin	Gabapentin	368	129
Omeprazole	Omeprazole	367	98
Metoprolol Succinate	Metoprolol Succinate	324	91
Amlodipine Besylate	Amlodipine Besylate	314	119
Lisinopril	Lisinopril	291	92
Levothyroxine Sodium	Levothyroxine Sodium	280	70
Furosemide	Furosemide	252	75
Tamsulosin Hcl	Tamsulosin Hcl	242	69
Metformin Hcl Er	Metformin Hcl	225	74
Pantoprazole Sodium	Pantoprazole Sodium	223	75
Rosuvastatin Calcium	Rosuvastatin Calcium	223	64
Losartan Potassium	Losartan Potassium	208	79
Doxycycline Monohydrate	Doxycycline Monohydrate	192	177
Methylprednisolone	Methylprednisolone	162	157
Trazodone Hcl	Trazodone Hcl	138	49
Azithromycin	Azithromycin	135	121
Allopurinol	Allopurinol	126	29
Hydralazine Hcl	Hydralazine Hcl	123	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	123	52
Glipizide Er	Glipizide	116	35
Montelukast Sodium	Montelukast Sodium	116	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	115	61
Potassium Chloride	Potassium Chloride	113	35
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	112	106
Metformin Hcl	Metformin Hcl	111	25
Jardiance	Empagliflozin	110	34
Fluticasone Propionate	Fluticasone Propionate	104	27
Carvedilol	Carvedilol	101	27
Ozempic	Semaglutide	101	19
Venlafaxine Hcl Er	Venlafaxine Hcl	101	12
Albuterol Sulfate Hfa	Albuterol Sulfate	100	51
Duloxetine Hcl	Duloxetine Hcl	95	28
Quetiapine Fumarate	Quetiapine Fumarate	95	12
Eliquis	Apixaban	93	31
Hydrochlorothiazide	Hydrochlorothiazide	91	30
Levofloxacin	Levofloxacin	91	81
Triamcinolone Acetonide	Triamcinolone Acetonide	80	56
Simvastatin	Simvastatin	77	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	76	72
Buspirone Hcl	Buspirone Hcl	73	17
Tramadol Hcl	Tramadol Hcl	73	41
Clonidine Hcl	Clonidine Hcl	72	25
Mirtazapine	Mirtazapine	72	17
Metoprolol Tartrate	Metoprolol Tartrate	71	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	23
Sertraline Hcl	Sertraline Hcl	69	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	25
Famotidine	Famotidine	65	20
Hydroxyzine Hcl	Hydroxyzine Hcl	64	29
Cephalexin	Cephalexin	63	58
Clopidogrel	Clopidogrel Bisulfate	61	15
Cefuroxime	Cefuroxime Axetil	60	46
Amitriptyline Hcl	Amitriptyline Hcl	59	23
Escitalopram Oxalate	Escitalopram Oxalate	59	17
Propranolol Hcl	Propranolol Hcl	57	17
Ventolin Hfa	Albuterol Sulfate	57	36
Bupropion Xl	Bupropion Hcl	54	14
Pravastatin Sodium	Pravastatin Sodium	52	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	17
Fluoxetine Hcl	Fluoxetine Hcl	49	15
Warfarin Sodium	Warfarin Sodium	47	18
Finasteride	Finasteride	46	12
Torsemide	Torsemide	46	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	12
Klor-Con M10	Potassium Chloride	42	suppressed
Linzess	Linaclotide	42	24
Baclofen	Baclofen	41	16
Nortriptyline Hcl	Nortriptyline Hcl	40	21
Ropinirole Hcl	Ropinirole Hcl	40	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Methocarbamol	Methocarbamol	38	23
Atenolol	Atenolol	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	14
Oxycodone Hcl	Oxycodone Hcl	35	17
Advair Hfa	Fluticasone Propion/Salmeterol	34	suppressed
Hydrocortisone	Hydrocortisone	33	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	31	suppressed
Nystatin	Nystatin	31	12
Valacyclovir	Valacyclovir Hcl	31	17
Alendronate Sodium	Alendronate Sodium	30	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Olanzapine	Olanzapine	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	12
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Ondansetron Odt	Ondansetron	27	24
Primidone	Primidone	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Ketoconazole	Ketoconazole	26	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Phenytoin	Phenytoin	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	20
Levetiracetam	Levetiracetam	25	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	25	22
Topiramate	Topiramate	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Lorazepam	Lorazepam	23	suppressed
Meloxicam	Meloxicam	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Erythromycin	Erythromycin Base	20	19
Ezetimibe	Ezetimibe	20	suppressed
Fluconazole	Fluconazole	20	18
Sucralfate	Sucralfate	20	14
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Cefdinir	Cefdinir	18	18
Fenofibrate	Fenofibrate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	17	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Amiloride Hcl	Amiloride Hcl	15	suppressed
Amoxicillin	Amoxicillin	15	14
Cholestyramine	Cholestyramine (With Sugar)	15	13
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	14	13
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	13
Naproxen	Naproxen	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Tirosint-Sol	Levothyroxine Sodium	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Terazosin Hcl	Terazosin Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error